Evaluation of ABT-751 against childhood cancer models in vivo Christopher L. MortonEdward G. FavoursPeter J. Houghton PRECLINICAL STUDIES 24 March 2007 Pages: 285 - 295
Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro Elin LindhagenLinda RickardsonAnna Ã…leskog PRECLINICAL STUDIES 18 April 2007 Pages: 297 - 303
Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines Denise K. WaltersRoman MuffBruno Fuchs PRECLINICAL STUDIES 26 April 2007 Pages: 305 - 312
A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance Gene L. Bidwell IIIAisha N. DavisDrazen Raucher PRECLINICAL STUDIES 05 May 2007 Pages: 313 - 326
Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry J. H. BeumerR. C. GarnerJ. H. M. Schellens PHASE I STUDIES Open access 09 March 2007 Pages: 327 - 334
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors Martee L. HensleyDon DizonCarol Aghajanian Phase I Studies 16 March 2007 Pages: 335 - 341
Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cells C. Anil KumarShankar JayaramaKanchugarakoppal S. Rangappa Phase I Studies 20 March 2007 Pages: 343 - 350
Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study Angela M DaviesCheryl HoDavid R Gandara PHASE I STUDIES 18 April 2007 Pages: 351 - 355
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes Quincy S. C. ChuBahram ForouzeshEric K. Rowinsky Erratum 13 April 2007 Pages: 357 - 357
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas Quincy S. C. ChuBahram ForouzeshEric K. Rowinsky Phase II Studies 20 January 2007 Pages: 359 - 367
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions Nancy U. LinLeroy M. ParkerLawrence N. Shulman Phase II Studies 08 March 2007 Pages: 369 - 375
Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study Koji TakedaNobuhide TakifujiHarumichi Ikegami PHASE II STUDIES 10 March 2007 Pages: 377 - 383
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers T. CiuleanuM. DiculescuP. A. Philip PHASE II STUDIES 16 March 2007 Pages: 385 - 390
Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway Pavel KrejciKaterina PejchalovaWilliam R. Wilcox SHORT REPORT 26 April 2007 Pages: 391 - 395
Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro soft-agar cloning experiments Axel-Rainer HanauskeOlaf OberschmidtUlrike Eismann Erratum 18 April 2007 Pages: 397 - 397